Literature DB >> 6606108

Evaluation of the Phadebact coagglutination test for the rapid serotyping of Haemophilus influenza.

S M Qadri, D Talbot.   

Abstract

Conventional tests for the indentification of Haemophilus species require 24-48 h for completion. In this study, we evaluated the Phadebact coagglutination method for the serotyping of Haemophilus that yields results within 2 min. Of the 150 strains tested, 148 were H. influenzae and 2 were H. parainfluenzae. Of the 83 H. influenzae isolates from cerebrospinal fluid and blood 80 were correctly typed as b by the Phadebact test. Of the 51 sputum isolates, 48 (94%) were nontypable. Eleven (69%) of the remaining sixteen isolates from secondary and unknown sources were type b, four (25%) were nontypable, and one (6%) was in the acdef group. Thirty gram-positive and gram-negative bacteria other than Haemophilus were also tested with no false-positive reactions. The Phadebact test is rapid and easy to perform and interpret.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606108     DOI: 10.1007/bf02123801

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  10 in total

1.  TYPING OF HAEMOPHILUS INFLUENZAE WITH FLUORESCENT ANTIBODY REAGENT.

Authors:  W W KARAKAWA; A K SEDGWICK; E K BORMAN
Journal:  Health Lab Sci       Date:  1964-04

2.  Serological methods for rapid diagnosis of haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae in cerebrospinal fluid: a comparison of Co-agglutination, immunofluorescence and immunoelectroosmophoresis.

Authors:  P Olcén
Journal:  Scand J Infect Dis       Date:  1978

3.  Biochemical characteristics of Haemophilus influenzae in relationship to source of isolation and antibiotic resistance.

Authors:  W L Albritton; S Penner; L Slaney; J Brunton
Journal:  J Clin Microbiol       Date:  1978-06       Impact factor: 5.948

4.  Haemophilus in the upper respiratory tract of children. A bacteriological, serological and clinical investigation.

Authors:  M Kilian; J Heine-Jensen; P Bülow
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

5.  Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Hemophilus infleunzae type b.

Authors:  D L Ingram; P Anderson; D H Smith
Journal:  J Pediatr       Date:  1972-12       Impact factor: 4.406

6.  Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination.

Authors:  H C Whittle; P Tugwell; L J Egler; B M Greenwood
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

7.  Determination of aetiology of bacterial meningitis by counter-immunoelectrophoresis.

Authors:  J D Coonrod; M W Rytel
Journal:  Lancet       Date:  1972-05-27       Impact factor: 79.321

8.  H. influenzae pneumonia in infants and children.

Authors:  P J Honig; P S Pasquariello; S E Stool
Journal:  J Pediatr       Date:  1973-08       Impact factor: 4.406

9.  Typing of Haemophilus influenzae by coagglutination and conventional slide agglutination.

Authors:  R G Shively; J T Shigei; E M Peterson; L M de la Maza
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

10.  The taxonomy and antimicrobial susceptibility of Haemophilus species in clinical specimens.

Authors:  R Golberg; J A Washington
Journal:  Am J Clin Pathol       Date:  1978-12       Impact factor: 2.493

  10 in total
  2 in total

1.  Identification of Haemophilus influenzae type b by a monoclonal antibody coagglutination assay.

Authors:  J Hamel; B R Brodeur; A Belmaaza; S Montplaisir; J M Musser; R K Selander
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

2.  International circumpolar surveillance interlaboratory quality control program for serotyping Haemophilus influenzae and serogrouping Neisseria meningitidis, 2005 to 2009.

Authors:  Raymond S W Tsang; Karen Rudolph; Marguerite Lovgren; Sadjia Bekal; Brigitte Lefebvre; Lotte Lambertsen; Tammy Zulz; Michael Bruce
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.